Cardinal Health, Inc.
Cash Flow Statement
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $1.71B | $1.56B | $852.0M | $330.0M | $-938.0M | $611.0M | $-3.70B | $1.36B |
| Depreciation & Amortization | $956.0M | $790.0M | $710.0M | $692.0M | $692.0M | $783.0M | $913.0M | $1.00B |
| Depreciation | $589.0M | $488.0M | $470.0M | $441.0M | $412.0M | $377.0M | $405.0M | $455.0M |
| Amortization | $361.0M | $303.0M | $264.0M | $281.0M | $311.0M | $428.0M | $512.0M | $531.0M |
| Stock-Based Compensation | $367.0M | $244.0M | $121.0M | $96.0M | $81.0M | $89.0M | $90.0M | $82.0M |
| Net Cash from Operating Activities | $5.17B | $2.40B | $3.76B | $2.84B | $3.18B | $2.43B | $1.96B | $2.72B |
| Investing Activities | ||||||||
| Capital Expenditures | $649.0M | $547.0M | $511.0M | $481.0M | $387.0M | $400.0M | $375.0M | $328.0M |
| Business Acquisitions | $1.99B | $5.25B | $1.19B | $10.0M | $22.0M | $3.0M | $0 | $82.0M |
| Net Cash from Investing Activities | $-2.58B | $-5.59B | $-1.85B | $-454.0M | $567.0M | $-378.0M | $493.0M | $338.0M |
| Financing Activities | ||||||||
| Dividends Paid | $491.0M | $494.0M | $499.0M | $525.0M | $559.0M | $573.0M | $569.0M | $577.0M |
| Stock Repurchases | $1.36B | $765.0M | $750.0M | $2.00B | $1.00B | $200.0M | $350.0M | $600.0M |
| Net Cash from Financing Activities | $-1.60B | $1.94B | $-847.0M | $-3.05B | $-2.46B | $-1.32B | $-2.20B | $-2.29B |
| Net Change in Cash | $982.0M | $-1.26B | $1.06B | $-669.0M | $1.36B | $636.0M | $240.0M | $768.0M |
| Free Cash Flow | $4.53B | $1.85B | $3.25B | $2.36B | $2.79B | $2.03B | $1.59B | $2.39B |